Contraception Oral Contraceptives

Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States

Wang YE, Kakigi C, Barbosa D, Porco T, Chen R, Wang S, Li Y, Singh K, Pasquale LR, Lin SC

Published April 2016 Ophthalmology, 123(4), 729-36
DOI 10.1016/j.ophtha.2015.11.029 PMID 26948305 PMC PMC4857187

RRM Academy Synopsis

Oral contraceptive use of 3+ years linked to self-reported glaucoma

A 2016 cross-sectional study of 3406 US women aged 40 and older found that oral contraceptive use of 3+ years was linked to higher odds of self-reported glaucoma. Participants reported their own glaucoma or ocular hypertension in a national survey. The adjusted odds ratio against no use was 1.94.

Key Findings

  • Three or more years of oral contraceptive use was associated with higher adjusted odds of self-reported glaucoma or ocular hypertension than no use (odds ratio 1.94, 95% confidence interval 1.22 to 3.07).
  • Of 3406 women, 231 self-reported glaucoma or ocular hypertension, which was 6.8% of the study population.
  • Older age (odds ratio 1.08), African American ethnicity (2.07) and later age at menarche (1.13) were also associated with higher adjusted odds of self-reported glaucoma or ocular hypertension.
  • Women who self-reported glaucoma or ocular hypertension more often had a cup-to-disc ratio above 0.7 (10.9% against 0.3%) and at least one visual field defect in either eye (22.3% against 6.4%).

Interpretation

This cross-sectional survey asked women to report their oral contraceptive history and whether they had glaucoma or ocular hypertension. In the unadjusted results, women with self-reported glaucoma were less likely to report three or more years of pill use. After adjusting for age, race, and age at menarche, the odds reversed: longer pill use was linked with higher glaucoma odds. The authors attribute this reversal to confounding by these factors. A Nurses' Health Study analysis cited by the authors found a 25% higher glaucoma risk after five or more years of use. The authors note a high average body mass index, which may limit how the finding generalizes. The findings support larger studies of this link.

RRM Context

Oral contraceptives block ovulation, and the authors hypothesize that this changes the natural daily variation in hormone levels that may matter in glaucoma. The paper notes estrogen receptors in several eye tissues. Restorative reproductive medicine treats the ovulatory cycle as a sign of health. The restorative approach asks what suppressive medications change beyond the symptom they treat. This study adds an eye outcome to that question.

Abstract

Purpose

To investigate the association between oral contraceptive (OC) use and glaucoma prevalence in the United States.

Design

Cross-sectional study.

Participants

A total of 3406 female participants, aged 40 years or older, from the 2005 to 2008 National Health and Nutrition Examination Survey, who reported a presence or absence of glaucoma or ocular hypertension completed both the vision and the reproductive health questionnaires and underwent eye examinations.

Methods

Multivariate regression analysis was used to assess the correlation between OC use and self-reported glaucoma or ocular hypertension (n = 231 cases), controlling for potential confounders, including age, ethnicity, systemic comorbidities such as hypertension and stroke, ocular diseases such as cataract and diabetic retinopathy, and reproductive health factors, including age at menopause, age at menarche, history of hormone replacement therapy, and gynecological surgical history.

Main Outcome Measures

The outcome variable was self-reported glaucoma or ocular hypertension.

Results

After adjusting for confounders, those with ≥3 years of OC use had greater odds (odds ratio, 1.94; 95% confidence interval, 1.22-3.07) of self-reported glaucoma or ocular hypertension. Other factors associated with higher glaucoma or ocular hypertension prevalence included older age, African American race, and later age at menarche.

Conclusions

Oral contraceptive use may be associated with increased risk of self-reported glaucoma or ocular hypertension.

Topics

Related research

Contraception › Oral Contraceptives › Cancer Risk
Ye Elaine Wang, Caitlin Kakigi, Diego Barbosa, Travis Porco, Rebecca Chen, Sophia Wang, Yingjie Li, Kuldev Singh, Louis R Pasquale, Shan C Lin
Y Wang, C Kakigi, D Barbosa, T Porco, Becky Chen, R Chen, S Wang, Y Li, K Singh, L Pasquale, S Lin
PMID 26948305 26948305 DOI 10.1016/j.ophtha.2015.11.029 10.1016/j.ophtha.2015.11.029 Wang et al. 2016, Wang 2016